132 related articles for article (PubMed ID: 27344317)
1. Cirrhotic patients have good insight into their daily functional impairment despite prior hepatic encephalopathy: comparison with PROMIS norms.
Bajaj JS; White MB; Unser AB; Ganapathy D; Fagan A; Gavis EA; Sterling RK; Heuman DM; Matherly S; Puri P; Sanyal AJ; Luketic V; Fuchs M; Siddiqui MS; Stravitz RT; John B; Thacker LR; Wade JB
Metab Brain Dis; 2016 Oct; 31(5):1199-203. PubMed ID: 27344317
[TBL] [Abstract][Full Text] [Related]
2. PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosis.
Bajaj JS; Thacker LR; Wade JB; Sanyal AJ; Heuman DM; Sterling RK; Gibson DP; Stravitz RT; Puri P; Fuchs M; Luketic V; Noble N; White M; Bell D; Revicki DA
Aliment Pharmacol Ther; 2011 Nov; 34(9):1123-32. PubMed ID: 21929591
[TBL] [Abstract][Full Text] [Related]
3. Symptom Domain Groups of the Patient-Reported Outcomes Measurement Information System Tools Independently Predict Hospitalizations and Re-hospitalizations in Cirrhosis.
Patidar KR; Thacker LR; Wade JB; White MB; Gavis EA; Fagan A; Sterling RK; Fuchs M; Siddiqui MS; Matherly S; Stravitz RT; Sanyal AJ; Puri P; Luketic VA; Bajaj JS
Dig Dis Sci; 2017 May; 62(5):1173-1179. PubMed ID: 28258378
[TBL] [Abstract][Full Text] [Related]
4. Cognitive reserve is a determinant of health-related quality of life in patients with cirrhosis, independent of covert hepatic encephalopathy and model for end-stage liver disease score.
Patel AV; Wade JB; Thacker LR; Sterling RK; Siddiqui MS; Stravitz RT; Sanyal AJ; Luketic V; Puri P; Fuchs M; Matherly S; White MB; Unser A; Heuman DM; Bajaj JS
Clin Gastroenterol Hepatol; 2015 May; 13(5):987-91. PubMed ID: 25445772
[TBL] [Abstract][Full Text] [Related]
5. Impact of depressive symptoms and hepatic encephalopathy on health-related quality of life in cirrhotic hepatitis C patients.
Barboza KC; Salinas LM; Sahebjam F; Jesudian AB; Weisberg IL; Sigal SH
Metab Brain Dis; 2016 Aug; 31(4):869-80. PubMed ID: 27032930
[TBL] [Abstract][Full Text] [Related]
6. Liver transplant candidates have impaired quality of life across health domains as assessed by computerized testing.
Stine JG; Stukenborg GJ; Wang J; Adkins A; Niccum B; Zimmet A; Argo CK
Ann Hepatol; 2020; 19(1):62-68. PubMed ID: 31558420
[TBL] [Abstract][Full Text] [Related]
7. Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis.
Ahluwalia V; Wade JB; Thacker L; Kraft KA; Sterling RK; Stravitz RT; Fuchs M; Bouneva I; Puri P; Luketic V; Sanyal AJ; Gilles H; Heuman DM; Bajaj JS
J Hepatol; 2013 Sep; 59(3):467-73. PubMed ID: 23665182
[TBL] [Abstract][Full Text] [Related]
8. Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues.
Montagnese S; Bajaj JS
Drugs; 2019 Feb; 79(Suppl 1):11-16. PubMed ID: 30706419
[TBL] [Abstract][Full Text] [Related]
9. Impact of physical and psychological factors on health-related quality of life in adult patients with liver cirrhosis: a systematic review protocol.
Polis S; Fernandez R
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):39-51. PubMed ID: 26447006
[TBL] [Abstract][Full Text] [Related]
10. Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis.
Arguedas MR; DeLawrence TG; McGuire BM
Dig Dis Sci; 2003 Aug; 48(8):1622-6. PubMed ID: 12924658
[TBL] [Abstract][Full Text] [Related]
11. Previous overt hepatic encephalopathy rather than minimal hepatic encephalopathy impairs health-related quality of life in cirrhotic patients.
Moscucci F; Nardelli S; Pentassuglio I; Pasquale C; Ridola L; Merli M; Riggio O
Liver Int; 2011 Nov; 31(10):1505-10. PubMed ID: 22093325
[TBL] [Abstract][Full Text] [Related]
12. The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers.
Bajaj JS; Wade JB; Gibson DP; Heuman DM; Thacker LR; Sterling RK; Stravitz RT; Luketic V; Fuchs M; White MB; Bell DE; Gilles H; Morton K; Noble N; Puri P; Sanyal AJ
Am J Gastroenterol; 2011 Sep; 106(9):1646-53. PubMed ID: 21556040
[TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients.
Labenz C; Baron JS; Toenges G; Schattenberg JM; Nagel M; Sprinzl MF; Nguyen-Tat M; Zimmermann T; Huber Y; Marquardt JU; Galle PR; Wörns MA
Aliment Pharmacol Ther; 2018 Aug; 48(3):313-321. PubMed ID: 29863286
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China.
Wang JY; Zhang NP; Chi BR; Mi YQ; Meng LN; Liu YD; Wang JB; Jiang HX; Yang JH; Xu Y; Li X; Xu JM; Zhang G; Zhou XM; Zhuge YZ; Tian DA; Ye J; Liu YL
World J Gastroenterol; 2013 Aug; 19(30):4984-91. PubMed ID: 23946605
[TBL] [Abstract][Full Text] [Related]
15. Minimal hepatic encephalopathy does not impair health-related quality of life in patients with cirrhosis: a prospective study.
Wunsch E; Szymanik B; Post M; Marlicz W; Mydłowska M; Milkiewicz P
Liver Int; 2011 Aug; 31(7):980-4. PubMed ID: 21733087
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of cognitive impairment in cirrhotic patients with bacterial infections.
Merli M; Lucidi C; Pentassuglio I; Giannelli V; Giusto M; Di Gregorio V; Pasquale C; Nardelli S; Lattanzi B; Venditti M; Riggio O
J Hepatol; 2013 Aug; 59(2):243-50. PubMed ID: 23523580
[TBL] [Abstract][Full Text] [Related]
17. Oral L-ornithine-L-aspartate improves health-related quality of life in cirrhotic patients with hepatic encephalopathy: an open-label, prospective, multicentre observational study.
Ong JP; Oehler G; Krüger-Jansen C; Lambert-Baumann J; Younossi ZM
Clin Drug Investig; 2011; 31(4):213-20. PubMed ID: 21208014
[TBL] [Abstract][Full Text] [Related]
18. Performance characterization of a novel electronic number connection test to detect minimal hepatic encephalopathy in cirrhotic patients.
Wuensch T; Ruether DF; Zöllner C; Mueller T; Jung T; Kaffarnik M; Kassner U; Schott E; Kiefer S; Pratschke J; Stockmann M; Jara M
Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):456-463. PubMed ID: 28092641
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of health-related quality of life in patients with systemic lupus erythematosus using PROMIS and Neuro-QoL.
Lai JS; Beaumont JL; Jensen SE; Kaiser K; Van Brunt DL; Kao AH; Chen SY
Clin Rheumatol; 2017 Mar; 36(3):555-562. PubMed ID: 27848056
[TBL] [Abstract][Full Text] [Related]
20. Predicting Hepatic Encephalopathy-Related Hospitalizations Using a Composite Assessment of Cognitive Impairment and Frailty in 355 Patients With Cirrhosis.
Ney M; Tangri N; Dobbs B; Bajaj J; Rolfson D; Ma M; Ferguson T; Bhardwaj P; Bailey RJ; Abraldes J; Tandon P
Am J Gastroenterol; 2018 Oct; 113(10):1506-1515. PubMed ID: 30267028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
